Trials / Completed
CompletedNCT01899040
A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Scion NeuroStim · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, blinded study designed to assess the efficacy of a portable, non-invasive neuromodulation system for the treatment of episodic migraine headaches.
Detailed description
This is a multi-center, triple-blinded, placebo-controlled, randomized pivotal trial evaluating the adjunctive prophylactic treatment of episodic migraine headache using a caloric vestibular stimulation (CVS) device developed by Scion NeuroStim, LLC (SNS). This study has been reviewed by the FDA and is categorized as posing NSR (nonsignificant risk).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | neuromodulation for episodic migraine headache |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2016-05-01
- Completion
- 2016-06-01
- First posted
- 2013-07-15
- Last updated
- 2025-05-31
- Results posted
- 2025-05-31
Locations
6 sites across 2 countries: United States, United Kingdom
Source: ClinicalTrials.gov record NCT01899040. Inclusion in this directory is not an endorsement.